Supernus Pharmaceuticals Inc (NAS:SUPN)
$ 37.51 0.49 (1.32%) Market Cap: 2.03 Bil Enterprise Value: 2.08 Bil PE Ratio: 58.61 PB Ratio: 2.38 GF Score: 85/100